journal article·2023-05Open access

Oleic Acid Dissolves cGAS–DNA Phase Separation to Inhibit Immune Surveillance

Lina Wang, Qiaoling Liu, Na Wang, Siru Li, Wei Bian, Zhen Sun, Lulu Wang, Li Wang, Caigang Liu, Chengli Song, Quentin Liu, Qingkai Yang

Advanced Science· Volume 10· Issue 14

Abstract

Abstract Phase separation (PS) is a fundamental principle in diverse life processes including immunosurveillance. Despite numerous studies on PS, little is known about its dissolution. Here, it is shown that oleic acid (OA) dissolves the cyclic GMP–AMP synthase (cGAS)–deoxyribonucleic acid (DNA) PS and inhibits immune surveillance of DNA. As solvent components control PS and metabolites are abundant cellular components, it is speculated that some metabolite(s) may dissolve PS. Metabolite‐screening reveals that the cGAS–DNA condensates formed via PS are markedly dissolved by long‐chain fatty acids, including OA. OA revokes intracellular cGAS–PS and DNA‐induced activation. OA attenuates cGAS‐mediated antiviral and anticancer immunosurveillance. These results link metabolism and immunity by dissolving PS, which may be targeted for therapeutic interventions.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune Cell Function and Interaction · interferon and immune responses · HIV Research and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Cancer Stem Cell DaLian Medical University Dalian 116 044 P. R. China

School of Life Science and Biotechnology Dalian University of Technology Dalian 116 024 P. R. China

CAS Key Laboratory of Separation Sciences for Analytical Chemistry Dalian Institute of Chemical Physics Chinese Academy of Sciences Dalian 116 023 P. R. China

Department of Oncology Shengjing Hospital of China Medical University Shenyang 110 004 P. R. China

Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Guangzhou 510 060 P. R. China

Funding

National Natural Science Foundation of China

References (64)

Show source-provided references
1. 10.1126/science.aaf438210.1126/science.aaf4382 ↗
2. 10.1016/j.cell.2018.12.03510.1016/j.cell.2018.12.035 ↗
3. 10.1038/s41577-021-00572-510.1038/s41577-021-00572-5 ↗
4. 10.1038/nri.2016.7810.1038/nri.2016.78 ↗
5. 10.1126/science.aad996410.1126/science.aad9964 ↗
6. 10.1126/science.aau572110.1126/science.aau5721 ↗
7. 10.1038/s41467-020-14544-110.1038/s41467-020-14544-1 ↗
8. 10.7554/eLife.1989110.7554/eLife.19891 ↗
9. 10.1126/science.aat102210.1126/science.aat1022 ↗
10. 10.1158/2159-8290.CD-19-076110.1158/2159-8290.CD-19-0761 ↗
11. 10.1016/j.immuni.2020.05.01310.1016/j.immuni.2020.05.013 ↗
12. 10.1016/j.cell.2010.06.01910.1016/j.cell.2010.06.019 ↗
13. 10.1038/s41568-021-00388-410.1038/s41568-021-00388-4 ↗
14. 10.1038/nrc317410.1038/nrc3174 ↗
15. 10.1038/nature0548210.1038/nature05482 ↗
16. 10.1159/00005581610.1159/000055816 ↗
17. 10.1016/S1473-3099(06)70523-010.1016/S1473-3099(06)70523-0 ↗
18. 10.1016/j.cell.2021.02.01210.1016/j.cell.2021.02.012 ↗
19. 10.1038/s41598-021-82213-410.1038/s41598-021-82213-4 ↗
20. 10.1001/jamaoncol.2018.563910.1001/jamaoncol.2018.5639 ↗
21. 10.1126/science.123245810.1126/science.1232458 ↗
22. 10.1126/science.122996310.1126/science.1229963 ↗
23. 10.1016/j.immuni.2013.10.01910.1016/j.immuni.2013.10.019 ↗
24. 10.1038/nature2389010.1038/nature23890 ↗
25. 10.1016/j.cell.2018.06.02610.1016/j.cell.2018.06.026 ↗
26. 10.1016/0076-6879(86)27032-910.1016/0076-6879(86)27032-9 ↗
27. 10.1126/science.aat865710.1126/science.aat8657 ↗
28. 10.1073/pnas.162136311410.1073/pnas.1621363114 ↗
29. 10.1016/j.ccell.2020.11.00910.1016/j.ccell.2020.11.009 ↗
30. 10.1126/science.124404010.1126/science.1244040 ↗
31. 10.1038/ni.238610.1038/ni.2386 ↗
32. 10.1016/S0022-2275(20)39899-010.1016/S0022-2275(20)39899-0 ↗
33. Kirsner R. S. · Ostomy Wound Manage · 1998 · 44 · 62S
34. 10.1038/s41589-020-0601-210.1038/s41589-020-0601-2 ↗
35. 10.1038/s41467-022-34858-610.1038/s41467-022-34858-6 ↗
36. 10.1093/nar/gkab24910.1093/nar/gkab249 ↗
37. 10.3390/genes1012104910.3390/genes10121049 ↗
38. 10.1021/bi201699e10.1021/bi201699e ↗
39. 10.1016/j.bbagen.2017.02.01810.1016/j.bbagen.2017.02.018 ↗
40. 10.1038/nature2347010.1038/nature23470 ↗
41. 10.1038/nature2344910.1038/nature23449 ↗
42. 10.1016/j.immuni.2020.03.01610.1016/j.immuni.2020.03.016 ↗
43. 10.1038/ni.209110.1038/ni.2091 ↗
44. 10.1016/j.immuni.2020.06.00910.1016/j.immuni.2020.06.009 ↗
45. 10.1002/hep.2178810.1002/hep.21788 ↗
46. 10.4137/LPI.S1080510.4137/LPI.S10805 ↗
47. 10.1016/j.immuni.2014.10.01910.1016/j.immuni.2014.10.019 ↗
48. 10.1038/nrclinonc.2015.12010.1038/nrclinonc.2015.120 ↗
49. 10.1038/s41568-020-0246-110.1038/s41568-020-0246-1 ↗
50. 10.1016/j.ccell.2020.11.00610.1016/j.ccell.2020.11.006 ↗
51. 10.1186/s13059-016-1070-510.1186/s13059-016-1070-5 ↗
52. 10.1016/j.molcel.2021.09.01010.1016/j.molcel.2021.09.010 ↗
53. 10.1016/S0022-2860(02)00256-910.1016/S0022-2860(02)00256-9 ↗
54. 10.1016/j.ccr.2010.08.00810.1016/j.ccr.2010.08.008 ↗
55. 10.1016/j.molcel.2022.03.03410.1016/j.molcel.2022.03.034 ↗
56. 10.1016/j.cell.2019.01.01610.1016/j.cell.2019.01.016 ↗
57. 10.1038/s41467-017-00833-910.1038/s41467-017-00833-9 ↗
58. 10.1016/j.ijbiomac.2013.03.02110.1016/j.ijbiomac.2013.03.021 ↗
59. Wilkins M. R. · Methods Mol. Biol. · 1999 · 112 · 531
60. 10.1038/s41586-021-04075-010.1038/s41586-021-04075-0 ↗
61. 10.1158/1078-0432.CCR-09-026510.1158/1078-0432.CCR-09-0265 ↗
62. 10.1038/s41419-020-2408-110.1038/s41419-020-2408-1 ↗
63. 10.1038/nature1125210.1038/nature11252 ↗
64. 10.1038/nature1343810.1038/nature13438 ↗